Blake Borgeson sold $98K of RXRX stock

Blake Borgeson, Dir of Recursion Pharmaceuticals, Inc. (RXRX), sold 30,000 shares of RXRX stock worth $98K, per an SEC Form 4 filed Aug 6, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 4, 2026, 2 days before it was made public.

RXRX has moved +6.3% since the trade date, from $3.31 to $3.52 (Nov 6, 2026 close).